Steve Hackley, Senior Vice President of Comcast Corporation (NASDAQ:CMCSA)’s Greater Boston Region was joined by City of Boston Chief of Health and Human Services Felix Arroyo and Boston Celtics Rookie Marcus Smart to officially kick off Internet Essentials, Comcast’s innovative broadband adoption initiative, for this school year at the Boston Centers For Youth Families Perkins Community Center in Dorchester. At the event, Comcast announced it will include up to six months of complimentary service for any new family in Boston and nationwide that has not yet applied for Internet Essentials. Families who are approved for Internet Essentials by September 20, 2014 will receive up to six months of Internet service. On Wednesday Comcast Corporation (NASDAQ:CMCSA) share price closed at $54.56. Company net profit margin stands at 11.20% whereas its return on equity (ROE) is 14.70%. Comcast Corporation (NASDAQ:CMCSA) is -3.42% away from its 52 week high and its 52 week range is $41.45 – 56.49.
One form of cancer that many in the medical field feel has been vastly under-researched is brain cancer. ImmunoCellular Therapeutics is another biotech company whose main focus is the development and commercialization of drugs and therapeutics geared toward fighting brain cancer. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) traded 531277 shares and its share price moved up 4.40% to close at $0.95. Company has 0.10% insider ownership. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) quarterly performance is -29.63% while its year to date (YTD) performance is 2.15%.
San Francisco-based Castlight Health, a developer of a Web applications providing consumers with healthcare cost and coverage data, has named Steve Singh, the CEO/chairman of Concur, to its board.On Wednesday shares of Castlight Health, Inc. (NYSE:CSLT) ended up at $11.38. This year Company’s Earnings per Share (EPS) growth is -80.00% and next year’s EPS growth is 29.70%. Castlight Health, Inc. (NYSE:CSLT) weekly performance is 2.34%.
SigmaTron International, Inc. (SGMA), an electronic manufacturing services company, on 22 July 2014 reported revenues and earnings for the fiscal year ended April 30, 2014. Revenues increased to $222.5 million in fiscal year 2014 from $198.4 million in the prior fiscal year. Net income increased to $2,918,691 in fiscal year 2014 compared to $492,961 in fiscal year 2013. Basic and diluted earnings per share for the fiscal year ended April 30, 2014 were $0.74 and $0.72, respectively compared to $0.13 and $0.12 in fiscal year 2013. For the fourth quarter of fiscal year 2014, revenues increased to $55.6 million compared to $51.3 million for the same quarter in the prior fiscal year. Basic and diluted earnings per share for the fiscal year 2014 fourth quarter were each $0.11 and $0.10 compared to basic and diluted earnings per share of $0.08 for the same period of fiscal year 2013. SigmaTron International Inc. (NASDAQ:SGMA) decreased -0.72% to close at $11.10 on 27 August. Its return on assets (ROA) is 3.20% while return on investment (ROI) is 4.40%. SigmaTron International Inc. (NASDAQ:SGMA) price to sales (P/S) ratio is 0.20.
Ohio Valley Banc Corp (NASDAQ:OVBC) VP Edgar R. Mahan sold 5,911 shares of the stock on the open market in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $22.97, for a total value of $135,775.67. Following the sale, the vice president now directly owns 5,349 shares in the company, valued at approximately $122,867. On 27 August Ohio Valley Banc Corp. (NASDAQ:OVBC) ended the day at $23.50. Company net profit margin stands at 21.90% whereas its return on equity (ROE) is 9.70%. Ohio Valley Banc Corp. (NASDAQ:OVBC) is -2.08% away from its 52 week high.